Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia
ABSTRACT: Hepatitis C virus (HCV) infection is one of the leading risk factors for end-stage liver disease development worldwide. This RNA virus displays high genetic diversity with 8 genotypes and 96 subgenotypes with heterogeneous geographical distribution around the world. In this study, we carri...
- Autores:
-
López Osorio, María Camila
Hoyos Duque, Sergio Iván
Restrepo Gutiérrez, Juan Carlos
Navas Navas, María Cristina
Usme Ciro, José Aldemar
Martínez, José William
Peláez Carvajal, Dioselina
Hernández, Javier
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2022
- Institución:
- Universidad de Antioquia
- Repositorio:
- Repositorio UdeA
- Idioma:
- eng
- OAI Identifier:
- oai:bibliotecadigital.udea.edu.co:10495/39793
- Acceso en línea:
- https://hdl.handle.net/10495/39793
- Palabra clave:
- Antivirales - Farmacología
Antiviral Agents - Pharmacology
Colombia - Epidemiología
Colombia - Epidemiology
Farmacorresistencia Viral
Drug Resistance, Viral
Enfermedad Hepática en Estado Terminal
End Stage Liver Disease
Hepacivirus
Hepatitis C
Funciones de Verosimilitud
Likelihood Functions
Mutación Missense
Mutation, Missense
Filogenia
Phylogeny
Seroepidemiologic Studies
Proteínas no Estructurales Virales
Viral Nonstructural Proteins
Estudios Seroepidemiológicos
Hepatitis C Crónica
Hepatitis C, Chronic
https://id.nlm.nih.gov/mesh/D000998
https://id.nlm.nih.gov/mesh/D003105
https://id.nlm.nih.gov/mesh/D024882
https://id.nlm.nih.gov/mesh/D058625
https://id.nlm.nih.gov/mesh/D016174
https://id.nlm.nih.gov/mesh/D006526
https://id.nlm.nih.gov/mesh/D016013
https://id.nlm.nih.gov/mesh/D020125
https://id.nlm.nih.gov/mesh/D010802
https://id.nlm.nih.gov/mesh/D016036
https://id.nlm.nih.gov/mesh/D017361
https://id.nlm.nih.gov/mesh/D019698
- Rights
- openAccess
- License
- http://creativecommons.org/licenses/by-nc-nd/2.5/co/
